Remove 2020 Remove Collaborations Remove Company Focus Remove Regulations
article thumbnail

Three Drivers of the M&A Rebound in 2H 2020

Velocity Global

M&A activity dropped during the first two quarters of 2020 after COVID-19 created economic conditions not seen since the Great Depression. As the business world adjusts to the new normal, executives regained confidence in their companies’ outlook and the global economy. Non-financial corporations in the U.S.

Payroll 52
article thumbnail

Six innovation strategies for Life Science organizations in 2023

IBM Services

David Volk, executive director of clinical supply chain planning at Roche states, “We are a networked organization… collaborating much more broadly across all our partners and the industry. The first AI-designed drug candidate to enter clinical trials was reported by Exscientia in early 2020.